SYN-TECH Chem. & Pharm. Co., Ltd. - Laporan Laba Rugi (TTM)

SYN-TECH Chem. & Pharm. Co., Ltd.
TW ˙ TPEX
NT$ 95.50 ↑0.20 (0.21%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi SYN-TECH Chem. & Pharm. Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,028 984 984 1,012 972 893 854 781 883 986 1,058 1,042 1,091 1,115 1,117 1,215 1,215 1,258 1,304 1,285
Change (%) -4.26 0.03 2.84 -3.97 -8.09 -4.44 -8.51 13.02 11.75 7.23 -1.45 4.66 2.19 0.22 8.76 0.02 3.49 3.66 -1.40
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 654 613 603 644 627 602 607 543 584 618 626 626 678 705 714 758 763 771 805 838
Change (%) -6.35 -1.58 6.82 -2.73 -3.97 0.88 -10.64 7.72 5.79 1.17 0.01 8.32 4.06 1.19 6.17 0.70 1.03 4.47 4.14
% of Revenue 63.68 62.30 61.30 63.67 64.49 67.38 71.13 69.47 66.22 62.69 59.14 60.02 62.12 63.26 63.87 62.34 62.77 61.28 61.76 65.23
Gross Operating Profit 373 371 381 368 345 291 246 238 298 368 432 417 413 410 404 458 452 487 498 447
Change (%) -0.61 2.67 -3.45 -6.14 -15.58 -15.42 -3.27 25.06 23.43 17.42 -3.56 -0.84 -0.89 -1.43 13.35 -1.12 7.63 2.37 -10.33
% of Revenue 36.32 37.70 38.70 36.33 35.51 32.62 28.87 30.53 33.78 37.31 40.86 39.98 37.88 36.74 36.13 37.66 37.23 38.72 38.24 34.77
SG&A 84 82 80 88 86 86 85 78 82 90 90 91 93 90 90 91 92 94 97 95
Change (%) -2.43 -2.19 10.41 -2.29 -0.17 -1.26 -8.22 4.26 10.27 0.49 0.42 2.00 -3.00 0.20 1.52 1.11 1.42 3.23 -1.40
% of Revenue 8.17 8.33 8.14 8.74 8.89 9.66 9.98 10.01 9.24 9.12 8.54 8.70 8.48 8.05 8.05 7.51 7.60 7.44 7.41 7.41
R&D 26 27 27 32 33 36 39 36 39 40 40 40 39 38 38 42 41 43 42 39
Change (%) 3.08 -0.21 20.03 4.74 9.22 5.92 -7.85 8.68 3.02 0.46 0.10 -1.60 -3.90 1.21 8.87 -1.62 3.45 -0.32 -7.79
% of Revenue 2.51 2.71 2.70 3.15 3.44 4.08 4.53 4.56 4.38 4.04 3.79 3.85 3.62 3.40 3.43 3.44 3.38 3.38 3.25 3.04
OpEx 764 721 710 765 747 725 731 656 705 748 756 756 810 833 842 891 896 907 944 973
Change (%) -5.60 -1.59 7.72 -2.37 -2.94 0.88 -10.21 7.36 6.15 1.05 0.06 7.04 2.86 1.08 5.79 0.63 1.18 4.11 3.03
% of Revenue 74.37 73.33 72.14 75.56 76.82 81.13 85.64 84.05 79.84 75.85 71.47 72.57 74.22 74.71 75.35 73.30 73.75 72.11 72.43 75.68
Operating Income 263 262 274 247 225 169 123 125 178 238 302 286 281 282 275 324 319 351 359 313
Change (%) -0.39 4.48 -9.77 -8.92 -25.17 -27.28 1.62 42.80 33.91 26.65 -5.25 -1.64 0.23 -2.31 17.84 -1.68 9.96 2.47 -13.03
% of Revenue 25.63 26.67 27.86 24.44 23.18 18.87 14.36 15.95 20.16 24.15 28.53 27.43 25.78 25.29 24.65 26.70 26.25 27.89 27.57 24.32
Interest Expense -4 -4 -3 -3 -3 -3 -4 -4 -5 -6 -6 -6 -6 -6 -6 -5 -4 -2 -1 -1
Change (%) -12.71 -20.69 -1.15 15.62 6.77 15.16 13.91 9.80 21.21 1.39 1.03 -0.96 -4.46 0.17 -14.77 -26.62 -40.45 -49.32 -21.84
% of Revenue -0.39 -0.36 -0.28 -0.27 -0.33 -0.38 -0.46 -0.57 -0.55 -0.60 -0.57 -0.58 -0.55 -0.51 -0.51 -0.40 -0.30 -0.17 -0.08 -0.07
Net Income 183 187 192 175 166 177 180 230 318 295 306 270 249 251 273 304 327 393 382 300
Change (%) 2.09 2.72 -8.73 -5.26 6.81 1.46 27.89 38.37 -7.17 3.71 -11.94 -7.73 0.87 8.71 11.38 7.75 20.09 -2.96 -21.48
% of Revenue 17.80 18.98 19.49 17.30 17.07 19.83 21.06 29.44 36.04 29.94 28.96 25.88 22.81 22.52 24.43 25.01 26.95 31.27 29.28 23.31

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista